VACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3 — Class II medical device recall Z-1714-2020
Terminated recall by Greiner Bio-One North America, Inc., reported 2020-04-22, distributed nationwide. Concerned lot of VACETTE 2mL 9NC Coagulation Tubes were shown to have inconsistent amounts of the 2.3% sodium
| Recall number | Z-1714-2020 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Greiner Bio-One North America, Inc., Monroe, NC, United States |
| Recall initiated | 2020-03-12 |
| Classified | 2020-04-15 |
| Reported by FDA | 2020-04-22 |
| Terminated | 2022-08-31 |
| Distributed | Nationwide (US) |
| Quantity | 1,000,800 units |
| UPC / GTIN / UDI-DI | 29120017574488 |
| Lot numbers | B1908355 |
| Model numbers | 454322 |
Product
VACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3.2%. Item no. 454322. Lot no. B1908355.
Reason for recall
Concerned lot of VACETTE 2mL 9NC Coagulation Tubes were shown to have inconsistent amounts of the 2.3% sodium citrate.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1714-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.